Literature DB >> 7563265

Human T-lymphotropic virus type-I, and hepatitis A, B and C viruses in Nepal: a serological survey.

K Nakashima1, S Kashiwagi, A Noguchi, M Hirata, J Hayashi, T Kawasaki, K Uezono, K Itoh, G P Acharya, M Ogata.   

Abstract

In 1987, 676 blood samples were collected from inhabitants of the Bhadrakali and Kotyang villages in Nepal. The samples were tested for the prevalence of antibody to hepatitis A virus (anti-HAV), hepatitis B surface antigen (HBsAg), antibody to hepatitis B core antigen (anti-HBc), second-generation antibody to hepatitis C virus (anti-HCV) and antibody to human T-lymphotropic virus type-I (anti-HTLV-I). Anti-HAV was present in 99.3% of the people surveyed. The prevalence of anti-HAV reached 100% in the < 25 age group and was as high or only slightly lower in all other age groups. The prevalence of HBsAg was 0.3% and of anti-HBc 7.7%. Anti-HCV was found in 0.1% of the residents. No significant difference by gender or village was noted in the prevalence of anti-HAV, HBsAg, anti-HBc, or anti-HCV. No anti-HTLV-I-positive persons were identified. These data suggest that the prevalence of hepatitis B and C virus infections in Nepal is low in contrast to hepatitis A virus infection, and that human T-lymphotropic type-I infection may be absent in this population.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7563265

Source DB:  PubMed          Journal:  J Trop Med Hyg        ISSN: 0022-5304


  2 in total

1.  Seroprevalence of HBV and HCV in blood donors: A study from regional blood transfusion services of Nepal.

Authors:  B R Tiwari; P Ghimire; S R Kandel; M Rajkarnikar
Journal:  Asian J Transfus Sci       Date:  2010-07

Review 2.  Seroprevalence of hepatitis B and C in Nepal: a systematic review (1973-2017).

Authors:  Marcelo Contardo Moscoso Naveira; Komal Badal; Jagadish Dhakal; Neichu Angami Mayer; Bina Pokharel; Ruben Frank Del Prado
Journal:  Hepatol Med Policy       Date:  2018-09-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.